Department of Medical and Toxicological Critical Care, Lariboisière Hospital, Federation of Toxicology, APHP, , Paris, France.
University of Paris, INSERM UMRS-1144, , Paris, France.
J Gen Intern Med. 2021 Mar;36(3):746-752. doi: 10.1007/s11606-020-06345-5. Epub 2021 Jan 13.
To date, the risk/benefit balance of lockdown in controlling severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) epidemic is controversial.
We aimed to investigate the effectiveness of lockdown on SARS-CoV-2 epidemic progression in nine different countries (New Zealand, France, Spain, Germany, the Netherlands, Italy, the UK, Sweden, and the USA).
We conducted a cross-country comparative evaluation using a susceptible-infected-recovered (SIR)-based model completed with pharmacokinetic approaches.
The rate of new daily SARS-CoV-2 cases in the nine countries was calculated from the World Health Organization's published data. Using a SIR-based model, we determined the infection (β) and recovery (γ) rate constants; their corresponding half-lives (t and t); the basic reproduction numbers (R as β/γ); the rates of susceptible S(t), infected I(t), and recovered R(t) compartments; and the effectiveness of lockdown. Since this approach requires the epidemic termination to build the (I) compartment, we determined S(t) at an early epidemic stage using simple linear regressions.
In New Zealand, France, Spain, Germany, the Netherlands, Italy, and the UK, early-onset stay-at-home orders and restrictions followed by gradual deconfinement allowed rapid reduction in SARS-CoV-2-infected individuals (t ≤ 14 days) with R ≤ 1.5 and rapid recovery (t ≤ 18 days). By contrast, in Sweden (no lockdown) and the USA (heterogeneous state-dependent lockdown followed by abrupt deconfinement scenarios), a prolonged plateau of SARS-CoV-2-infected individuals (terminal t of 23 and 40 days, respectively) with elevated R (4.9 and 4.4, respectively) and non-ending recovery (terminal t of 112 and 179 days, respectively) was observed.
Early-onset lockdown with gradual deconfinement allowed shortening the SARS-CoV-2 epidemic and reducing contaminations. Lockdown should be considered as an effective public health intervention to halt epidemic progression.
迄今为止,封锁措施控制严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)疫情的风险/收益平衡仍存在争议。
我们旨在研究封锁措施对九个不同国家(新西兰、法国、西班牙、德国、荷兰、意大利、英国、瑞典和美国)SARS-CoV-2 疫情进展的影响。
我们使用基于易感-感染-恢复(SIR)的模型并结合药代动力学方法进行了跨国比较评估。
从世界卫生组织发布的数据中计算了九个国家的每日新增 SARS-CoV-2 病例数。我们使用基于 SIR 的模型确定了感染(β)和恢复(γ)速率常数;相应的半衰期(t 和 t);基本繁殖数(R 为β/γ);易感 S(t)、感染 I(t)和恢复 R(t)的比例;以及封锁的有效性。由于这种方法需要疫情结束才能构建(I)部分,因此我们使用简单线性回归在疫情早期确定 S(t)。
在新西兰、法国、西班牙、德国、荷兰、意大利和英国,早期实施居家令和限制措施,随后逐步放宽限制,使得 SARS-CoV-2 感染人数迅速减少(t ≤ 14 天,R ≤ 1.5),恢复速度较快(t ≤ 18 天)。相比之下,在瑞典(无封锁)和美国(各州根据情况实施不同的封锁措施,随后突然放宽限制),SARS-CoV-2 感染人数持续居高不下(末期 t 分别为 23 天和 40 天,R 分别为 4.9 和 4.4),恢复时间也较长(末期 t 分别为 112 天和 179 天)。
早期实施封锁并逐步放宽限制,可缩短 SARS-CoV-2 疫情并减少感染。封锁应被视为阻止疫情进展的有效公共卫生干预措施。